Both in Pharmaceuticals
Avalo Therapeutics vs Atea Pharmaceuticals
Over the past year AVTX returned −62.4% and AVIR returned +28.0%; their daily moves had a correlation of 0.18.
AVTX −62.4% AVIR +28.0%Growth of $1, one year, split-adjusted
| Metric | AVTX | AVIR |
|---|---|---|
| Price | $6.77 | $4.16 |
| Market cap | $363.1M | $333.7M |
| Today | −2.31% | +2.97% |
| 1 month | −56.2% | −19.5% |
| 6 months | −53.1% | −22.4% |
| Year to date | −62.7% | +16.5% |
| 1 year | −62.2% | +30.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 6,153.8× | — |
| Net cash | $400.3M | $219.5M |
| Dividend yield | — | — |
| Volatility (60d) | 113.7% | 46.7% |
| Short % of float | 24.6% | 5.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).